Rockbridge Investment Management, Lcc Merck & Co., Inc. Transaction History

Rockbridge Investment Management, Lcc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $230,414 - $250,746	-2,300 Reduced 60.65%	1,492 $163 Million
Q3 2022 May 28, 2024	SELL	$84.53 - $94.96 $140,742 - $158,108	-1,665 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$83.49 - $94.64 $185,097 - $209,816	-2,217 Reduced 57.11%	1,665 $151,000
Q1 2022 May 28, 2024	BUY	$73.51 - $82.4 $285,365 - $319,876	3,882 New	3,882 $318,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $25,876 - $32,413	358 Added 10.43%	3,792 $291,000
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $3,655 - $4,020	51 Added 1.51%	3,434 $257,000
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $2,179 - $2,410	31 Added 0.92%	3,383 $263,000
Q1 2021 May 20, 2021	SELL	$68.86 - $81.11 $387,681 - $456,649	-5,630 Reduced 62.68%	3,352 $258,000
Q4 2020 Mar 04, 2021	BUY	$71.77 - $79.65 $71 - $79	1 Added 0.01%	8,982 $735,000
Q3 2020 Nov 03, 2020	BUY	$73.18 - $82.95 $73 - $82	1 Added 0.01%	8,981 $745,000
Q2 2020 Aug 20, 2020	BUY	$70.42 - $80.13 $632,371 - $719,567	8,980 New	8,980 $694,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.